QA ONLY: FDAs Regulation of Over-the-Counter Monograph Drugs 04-01-25 - Energy & Commerce

00:10:07 Is Over-the-Counter Drug Reauthorization Right?
00:21:52 FDA Staffing Cuts Will Have a Direct Impact on Medication Safety
00:31:56 FDA needs to be transparent and open to ensure a successful reauthorization
00:42:01 Does the Monograph Process Cut Red Tape Speed Up the Path?
00:52:01 How to Prevent Skin Cancer in the U.S.
01:05:11 Increasing Access to Over-the-Counter Medications
01:17:49 Keeping Up With FDA Monograph Updates for Small OTC Drug Manufacturers
01:31:56 More delays in approving new affordable over-the-counter treatments
01:43:01 How the FDA's approach to sunscreen filters has hindered innovation

The hearing is on the over-the-counter monograph drug user fee program referred to as MFA. The program reformed and modernized the regulation of OTC monograph drugs and authorized the FDA to assess and collect user fees. The current legislative authority for MFA expires September the 30th 2025.

Summary generated by AI

This is just the direct questions and answers portion of the hearing, not commentary.
Full video at https://www.youtube.com/watch?v=OVcSlc8fsxI.
Let me know if the full video link is down and I'll upload the full version.